Director/PDMR Shareholding
Faron Pharmaceuticals Ltd. announced that its Chief Financial Officer, Jurriaan Dekkers, sold 4,000 ordinary shares at £1.822 per share on January 12, 2026. This transaction resulted in Mr. Dekkers holding zero ordinary shares, representing 0.0% of the company's voting rights. The sale occurred on the London Stock Exchange's AIM market.
Select text to share a quote on X · sign in to keep highlights & notes in your FARN notes
| Faron Pharmaceuticals Ltd | Company announcement | January 13, 2026 at 18:00:00 EET |
TURKU, FINLAND – Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on developing novel immunotherapies, announces today that Mr. Jurriaan Dekkers, Chief Financial Officer of the Company, sold 4,000 ordinary shares in Faron at price of £1.822 per share on 12 January 2026.
Further details are set out in the Notification of Dealing Form below.
| PDMR | Holding prior to sale | Number of ordinary shares sold | Resultant interest in ordinary shares in the Company | Resultant percentage of voting rights in the Company |
|---|---|---|---|---|
| Jurriaan Dekkers | 4,000 | 4,000 | 0 | 0.0% |
About Faron Pharmaceuticals Ltd.
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
| a. | Name | Jurriaan Dekkers |
| 2 | Reason for notification | |
| a. | Position/Status | Chief Financial Officer |
| b. | Initial notification/ Amendment | Initial Notification |
| a. | Name | Faron Pharmaceuticals Ltd. |
| b. | LEI | 7437009H31TO1DC0EB42 |
| a. | Description of the financial instrument, type of instrument Identification Code | Ordinary Shares ISIN: FI4000153309 |
| b. | Nature of the transaction | Sale of Ordinary Shares |
| Price(s) per share (p) | Volume(s) | |
| £1.822 | 4,000 | |
| d. | Aggregated information Volume Price | 4,000 £1.822 |
| f. | Place of the transaction | London Stock Exchange, AIM |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.